New COVID-19 vaccine, CoVac-1, offers better protection to immunocompromised patients, study reveals
A new COVID-19 vaccine has shown signs of inducing strong immune response especially in immonocompromised patients including those suffering from cancers like leukaemic and lymphoma. The findings of this response which was presented at the American Academy of Cancer Research (AACR) Annual Meeting in Louisiana, United States on Tuesday comes as early results from a … Read more